This page shows the latest Galvani Bioelectronics news and features for those working in and with pharma, biotech and healthcare.
The alliance with Gilead adds to Verily’s joint ventures with GSK, Galvani Bioelectronics and with Sanofi’s diabetes management platform Onduo.
medicines. Galvani Bioelectronics - named for the 18th century Italian bioelectricity pioneer - will combine GSK's drug discovery and development expertise in disease biology with Verily's expertise in highly miniaturised technologies, ... The UK pharma
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
For example, Gilead collaborated with Google’s Verily to study immunological disorders, and GlaxoSmithKline partnered with Google’s parent company Alphabet to found Galvani Bioelectronics.
There was the August announcement that Google's Verily company was investing in the development of bioelectronic medicines with GSK via the newly formed Galvani Bioelectronics.
GSK will hold 55% of the shares in Galvani Bioelectronics, which will seek to develop miniaturised devices, attached to individual nerves to correct irregular electrical signals that are characteristic of certain ... Galvani Bioelectronics set up to
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Dr Slaoui takes on the role alongside his other board positions, which include chairman of the board at Galvani Bioelectronics, and on the boards of Artisan Biosciences, Moderna Therapeutics and Sutovax.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Such as the GSK/Verily joint venture called Galvani Bioelectronics and the Novartis/Verily joint venture to develop an autofocus contact lens.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...